dobutamine has been researched along with cyclic gmp in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, G; Gerzer, R; Stangl, K; Weil, J | 1 |
| Eskinder, H; Gross, GJ | 1 |
| Armstead, WM; Devine, JO; Rebich, S | 1 |
| Satake, N; Shibata, S; Zhou, Q | 1 |
| Balligand, JL; Colucci, WS; Hare, JM; Keaney, JF; Loscalzo, J; Smith, TW | 1 |
| Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH | 1 |
| Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Mochizuki, M; Ohkusa, T; Ono, K; Tanigawa, T; Yamada, J; Yano, M | 1 |
| Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM | 1 |
| Hare, JM; Isoda, T; Juang, GJ; Kass, DA; Mayer, SP; Ohler, A; Paolocci, N; Senzaki, H; Smith, CJ; Tomaselli, GF | 1 |
| Frantz, S; Kelly, RA; Paulus, WJ | 1 |
| Barclay, JK; Reading, SA | 1 |
11 other study(ies) available for dobutamine and cyclic gmp
| Article | Year |
|---|---|
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
8-Bromo cyclic GMP mimics the actions of nitroglycerin in modulating responses produced by full and partial alpha-adrenoceptor agonists in canine saphenous vein.
Topics: Adrenergic alpha-Agonists; Animals; Cyclic GMP; Dobutamine; Dogs; In Vitro Techniques; Nitroglycerin; Phenylephrine; Saphenous Vein; Vasoconstriction; Vasodilation | 1988 |
Role of nitric oxide and cAMP in beta-adrenoceptor-induced pial artery vasodilation.
Topics: Albuterol; Amino Acid Oxidoreductases; Animals; Animals, Newborn; Arginine; Colforsin; Cyclic AMP; Cyclic GMP; Dobutamine; Enzyme Activation; Female; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Pia Mater; Receptors, Adrenergic, beta; Swine; Vasodilation | 1995 |
Inhibitory effect of sodium nitroprusside on the relaxing action of isoproterenol in isolated rat urinary bladder.
Topics: Animals; Cyclic GMP; Dobutamine; Electric Stimulation; In Vitro Techniques; Isoproterenol; Male; Methylene Blue; Muscle Relaxation; Nitroprusside; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Urinary Bladder | 1994 |
Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Animals; Coronary Vessels; Cyclic GMP; Dobutamine; Dogs; Enzyme Inhibitors; Female; Heart; Injections; Isoproterenol; Male; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ventricular Function | 1996 |
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism | 1999 |
Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Hemodynamics; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Rolipram; Sarcoplasmic Reticulum; Ventricular Function, Left | 2000 |
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left | 2001 |
Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiac Output, Low; Colforsin; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dobutamine; Dogs; Female; Heart; Hemodynamics; Immunohistochemistry; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Piperazines; Purines; Purinones; Pyrazoles; Receptors, Adrenergic, beta; Signal Transduction; Sildenafil Citrate; Sulfones | 2001 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
The inotropic effect of nitric oxide on mammalian papillary muscle is dependent on the level of beta1-adrenergic stimulation.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cats; Cyclic GMP; Dobutamine; Drug Synergism; Electric Stimulation; Endothelium, Vascular; Female; In Vitro Techniques; Isometric Contraction; Male; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Papillary Muscles; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents | 2002 |